Multicenter Evaluation of the Clinical Performance and the Neutralizing Antibody Activity Prediction Properties of 10 High-Throughput Serological Assays Used in Clinical Laboratories

As the coronavirus disease 2019 (COVID-19) pandemic second wave is emerging, it is of the upmost importance to screen the population immunity in order to keep track of infected individuals. Consequently, immunoassays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with high specific...

Descripción completa

Detalles Bibliográficos
Autores principales: Therrien, C., Serhir, B., Bélanger-Collard, M., Skrzypczak, J., Shank, D. K., Renaud, C., Girouard, J., Loungnarath, V., Carrier, M., Brochu, G., Tourangeau, F., Gilfix, B., Piche, A., Bazin, R., Guérin, R., Lavoie, M., Martel-Laferrière, V., Fortin, C., Benoit, A., Marcoux, D., Gauthier, N., Laumaea, A. M., Gasser, R., Finzi, A., Roger, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Immunoassays
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106733/
https://www.ncbi.nlm.nih.gov/pubmed/33303562
http://dx.doi.org/10.1128/JCM.02511-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106733/
https://www.ncbi.nlm.nih.gov/pubmed/33303562
http://dx.doi.org/10.1128/JCM.02511-20

Ejemplares similares